Elevance Health Inc (NYSE:ELV) currently has a daily average trading volume of 1.87M but it saw 2210512 shares traded in last market. With a market cap of 84.94B USD, the company’s current market price of $366.26 came falling about -0.01 while comparing to the previous closing price of $366.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $567.26 and as low as $363.54. In the recent trading on the day, stock has struck highest price mark of $364.71 while lowest mark touched by it was $374.39.
Taking a look at 20-day trading activity of Elevance Health Inc (ELV) gives us an average price of $392.67, while its current price level is -35.43% below from 52-week high level whereas it is 0.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $416.69 while that of 200 days or SMA-200 reads an average of $500.02. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.12% during that period while stretching the period over a month that decreases to 2.51%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 28.87 which implies that the stock is in oversold territory.
BofA Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on July 18, 2024 while assigning a price target range of $646-$530. Morgan Stanley issued its recommendations for the stock as it initiated the price target for the stock is $643.
Over the week, ELV’s stock price is moving -5.01% down while it is -8.59% when we observe its performance for the past one month. Year-to-date it is -22.33% down and over the past year, the stock is showing a downside performance of -21.97%.
Currently, Elevance Health Inc’s total number of outstanding shares is 231.93M. Company’s return on investment (ROI) stands at 9.37% and return on equity (ROE) at 15.62%. It has a price to earnings ratio (P/E ratio) of 13.35 while having a 10.49 of forward P/E ratio. Stock’s beta reads 0.84. Stock has a price to book (P/B) ratio of 1.94 while price to sale or P/S ratio amounts to 0.49. Its return on asset (ROA) is 5.65% on average.
